Our ambition is to position Sandoz Canada as THE leader in Biosimilars & Generics powered by our people, portfolio and pipeline to serve as a trusted partner to pharmacies, hospitals, physicians and payers.
Sandoz Canada is part of Sandoz International GmbH which is a subsidiary of Swiss multinational Novartis AG. Our global purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2018 sales of USD 9.9 billion. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area.